Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000196705 | SCV000254011 | benign | Familial adenomatous polyposis 1 | 2025-01-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000216893 | SCV000273092 | likely benign | Hereditary cancer-predisposing syndrome | 2019-11-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Counsyl | RCV000196705 | SCV000489348 | uncertain significance | Familial adenomatous polyposis 1 | 2016-09-26 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000589545 | SCV000490404 | likely benign | not provided | 2019-05-29 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 24728327, 28615371, 29753010, 30093976) |
Color Diagnostics, |
RCV000216893 | SCV000681635 | likely benign | Hereditary cancer-predisposing syndrome | 2020-04-07 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000120050 | SCV000694039 | likely benign | not specified | 2024-07-08 | criteria provided, single submitter | clinical testing | Variant summary: APC c.385G>C (p.Glu129Gln) results in a conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 9.1e-05 in 252804 control chromosomes (gnomAD and Bodian_2014). The observed variant frequency is approximately 1 fold of the estimated maximal expected allele frequency for a pathogenic variant in APC causing Familial Adenomatous Polyposis phenotype (7.1e-05). c.385G>C has been reported in the literature in individuals affected with Familial Adenomatous Polyposis, without strong evidence for causality (Chan_2018). These report(s) do not provide unequivocal conclusions about association of the variant with Familial Adenomatous Polyposis. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 24728327, 30093976). ClinVar contains an entry for this variant (Variation ID: 133539). Based on the evidence outlined above, the variant was classified as likely benign. |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000589545 | SCV001470644 | likely benign | not provided | 2019-12-13 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000216893 | SCV002536137 | likely benign | Hereditary cancer-predisposing syndrome | 2022-01-06 | criteria provided, single submitter | curation | |
Myriad Genetics, |
RCV000196705 | SCV004018773 | likely benign | Familial adenomatous polyposis 1 | 2023-02-21 | criteria provided, single submitter | clinical testing | This variant is considered likely benign. This variant has been observed at a population frequency that is significantly greater than expected given the associated disease prevalence and penetrance. |
Center for Genomic Medicine, |
RCV000120050 | SCV004025026 | likely benign | not specified | 2025-03-04 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV005359132 | SCV005913522 | uncertain significance | Desmoid disease, hereditary; Familial adenomatous polyposis 1 | 2021-03-25 | criteria provided, single submitter | clinical testing | |
ITMI | RCV000120050 | SCV000084186 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
Laboratory of Diagnostic Genome Analysis, |
RCV000589545 | SCV001799446 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000589545 | SCV001922571 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004739410 | SCV005362789 | likely benign | APC-related disorder | 2024-05-16 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |